Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Medicine Reports is Scopus-indexed (Q1, CiteScore 7.3), WoS SCIE. Published by Spandidos Publications.
Checked against the index lists dated .
ISSN 1791-2997Verify ISSN ↗1791-3004Verify ISSN ↗
Publisher: Spandidos Publications
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 81 / 428 | 81st | Q1 |
| Genetics | 83 / 357 | 76th | Q1 |
| Biochemistry | 116 / 448 | 74th | Q2 |
| Cancer Research | 73 / 233 | 68th | Q2 |
| Molecular Medicine | 57 / 179 | 68th | Q2 |
| Molecular Biology | 132 / 414 | 68th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 7.3.
Molecular Medicine Reports is Q1 in Oncology (rank 81 of 428), Q1 in Genetics (rank 83 of 357) and Q2 in Biochemistry (rank 116 of 448), by CiteScore 2025. It is ranked in 6 subject areas in all.
Molecular Medicine Reports is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.3, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.933, quartile Q2, with an H-index of 106.
Molecular Medicine Reports is published by Spandidos Publications. Its print ISSN is 1791-2997 and its online ISSN is 1791-3004.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Molecular Medicine Reports has an h-index of 114 and a 2-year mean of 5.38 citations per paper (OpenAlex). Its Scopus CiteScore is 7.3, quartile Q1. On 2-year citations it ranks #50 of 424 Scopus journals in Oncology.
Molecular Medicine Reports published 359 papers in 2025; its busiest recent year was 2017 with 2,269. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2026), authors are most often from China (87%), South Korea (2.7%) and Germany (2.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 517 retracted papers are recorded (36.6 per 1,000 papers). The Problematic Paper Screener flags 20 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.